INTERNATIONAL PATENT: PASITHEA THERAPEUTICS CORP. FILES APPLICATION FOR "10,11-DIFLUORO-12-((2-FLUORO-4-IODOPHENYL)AMINO)-5,6-DIHYDROXY-4,5,6,7-TETRAHYDRO-1H-SPIRO[BENZO[B][1,5,4]OXATHIAZECINE-3,1'-CYCLOPROPANE] 2,2-DIOXIDE STEREOISOMERS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME"

GENEVA, July 14 -- PASITHEA THERAPEUTICS CORP. (1111 Lincoln RoadSuite 500Miami, FL 33139) filed a patent application (PCT/US2025/010070) for "10,11-DIFLUORO-12-((2-FLUORO-4-IODOPHENYL)AMINO)-5,6-DIHYDROXY-4,5,6,7-TETRAHYDRO-1H-SPIRO[BENZO[B][1,5,4]OXATHIAZECINE-3,1'-CYCLOPROPANE] 2,2-DIOXIDE STEREOISOMERS, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME" on Jan 02, 2025. With publication no. WO/2025/147503, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAZARUS, Mathew (1111 Lincoln RoadSuite 500Miami, FL 3313...